Search Stock News and Analysis

Mylan Call Options Hot as Stock Hits New Low

https://www.schaeffersresearch.com/content/options/2019/05/13/mylan-call-options-hot-as-stock-hits-new-low

5/13/2019 2:10 PM

It's been a rough stretch for Mylan NV (NASDAQ:MYL) stock, which is down more than 30% since its May 6 intraday peak at $28.46, due in part to last week's post-earnings bear gap. Options traders hav...

Teva Pharmaceutical Put Volume Pops on Lawsuit Woes

https://www.schaeffersresearch.com/content/options/2019/05/13/teva-pharmaceutical-put-volume-pops-on-lawsuit-woes

5/13/2019 10:43 AM

Drugmaker Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is tanking this morning, last seen down 12.7% at $12.53, after several U.S. states filed a price-fixing lawsuit against the company, accusing i...

Teva Pharmaceutical Option Bull Makes a Bold Bet

https://www.schaeffersresearch.com/content/options/2019/03/26/teva-pharmaceutical-option-bull-makes-a-bold-bet

3/26/2019 2:21 PM

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is in the news today, after OxyContin maker Purdue Pharma and several members of the Sackler family, which own the company, reached a $270 million settle...

Stocks Climb Ahead of Fed Minutes as Nasdaq Eyes Elite Eight

https://www.schaeffersresearch.com/content/ezines/2019/02/20/stocks-climb-ahead-of-fed-minutes-as-nasdaq-eyes-elite-eight

2/20/2019 11:48 AM

The Dow Jones Industrial Average (DJI) is clinging to marginal gains at midday, as investors await the release of the latest Fed meeting minutes. There are no new trade developments between the U.S...

Teva Pharmaceutical Gaps Lower After Profit, Guidance Bomb

https://www.schaeffersresearch.com/content/news/2019/02/13/teva-pharmaceutical-gaps-lower-after-profit-guidance-bomb

2/13/2019 10:00 AM

The shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) have plunged 10% out of the gate to trade at $17.17, after the generic drugmaker reported a fourth-quarter adjusted profit miss of 53 cent...

PEOPLE ALSO SEARCH FOR